NeoGenomics Inc. (NEO) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for NeoGenomics Inc., updated every trading day.
Health Care · Precision Instruments
Price
$17.99
+4.17% today
Market cap
$2.2B
Overall quality
—
Kronos AI 30-day
−13.8%
0 of 8 simulated paths end higher
NeoGenomics Inc. (NEO) is a Health Care company in Precision Instruments, worth $2.2B. It trades at $17.99, up 4.17% today. 7 analysts' average target of $22.00 implies +22.3% from today's price. Kronos AI's 30-day forecast is −13.8% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $22.00 |
| Low – high | $19.00 – $28.00 |
| Analysts | 7 |
| Upside to average | +22.3% |
Kronos AI 30-day forecast
| Expected close | $14.89 (−13.8%) |
| Likely range | −27.7% … −6.7% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Precision Instruments
For information only, not investment advice. Prices updated: 2026-10-29.